Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis
Clinical trial NCT03302806 · COMPLETED
Trial details
- NCT number
- NCT03302806
- Sponsor
- Nantes University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-06-29
- Primary completion
- 2017-10-04
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.